Belarus plans to produce own vaccine at two sites: BelVitunipharm and Belmedpreparaty
<p> MINSK, Aug 12 - PrimePress. Belarus plans to produce its own vaccine in two stages - at BelVitunifarm and state enterprise Belmedpreparaty, Director General of Belmedpreparaty Sergey Beliayev told the press on August 12. </p> <p> </p> <p> “Two sites are planned to be engaged in the first stage. They are BelVitunifarm with regard to their experience in vaccines. They will produce the active ingredient. And Belmedpreparaty will assemble the vaccine as a drug and produce the final form. These samples will be submitted for clinical trials in order to study their effectiveness and safety in human studies,” the Health Ministry official Telegram channel reports citing Beliayev as saying. </p> <p> </p> <p> In his words, Belmedpreparaty has experience with vaccines, while the Russian vaccine against COVID-19 Sputnik V is currently produced. He said that it is still premature to speak about the volume of production of the domestic vaccine. For the time being, one can only state that a prototype of the vaccine has been created and that the technological approach to be implemented for its production has been determined. End </p>
2021-08-13
Primepress
Belarus plans to produce own vaccine at two sites: BelVitunipharm and Belmedpreparaty
MINSK, Aug 12 - PrimePress. Belarus plans to produce its own vaccine in two stages - at BelVitunifarm and state enterprise Belmedpreparaty, Director General of Belmedpreparaty Sergey Beliayev told the press on August 12.
“Two sites are planned to be engaged in the first stage. They are BelVitunifarm with regard to their experience in vaccines. They will produce the active ingredient. And Belmedpreparaty will assemble the vaccine as a drug and produce the final form. These samples will be submitted for clinical trials in order to study their effectiveness and safety in human studies,” the Health Ministry official Telegram channel reports citing Beliayev as saying.
In his words, Belmedpreparaty has experience with vaccines, while the Russian vaccine against COVID-19 Sputnik V is currently produced. He said that it is still premature to speak about the volume of production of the domestic vaccine. For the time being, one can only state that a prototype of the vaccine has been created and that the technological approach to be implemented for its production has been determined. End